A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period
Clinical trial NCT02587195 · COMPLETED
Trial details
- NCT number
- NCT02587195
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-18
- Primary completion
- 2020-08-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.